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ttp://dx.doi.org/10.1016/j.ajpath.2012.10.019There are two major haplotypes of signal lymphocytic activation molecule (Slam) in inbred mouse
strains, with the Slam haplotype 1 expressed in C57Bl/6 mice and the Slam haplotype 2 expressed in
most other commonly used inbred strains, including 129 mice. Because signaling through Slam family
receptors can affect innate immunity [natural killer T cell (NKT) and g-d T-cell receptor], and innate
immunity can determine susceptibility to coxsackievirus B3 (CVB3) infection, the present study eval-
uated the response of C57Bl/6 and congenic B6.129c1 mice (expressing the 129-derived Slam locus) to
CVB3. CVB3-infected C57Bl/6 male mice developed increased myocarditis but reduced hepatic injury
compared with infected B6.129c1 mice. C57Bl/6 mice also had increased gdþ and CD8þinterferon-gþ
cells but decreased numbers of NKT (T-cell receptor b chain þ mCD1d tetramerþ) and CD4þFoxP3þ cells
compared with B6.129c1 mice. C57Bl/6 mice were infected with CVB3 and treated with either a-gal-
actosylceramide, an NKT cell-speciﬁc ligand, or vehicle (dimethyl sulfoxide/PBS). Mice treated with
a-galactosylceramide showed signiﬁcantly reduced myocarditis. Liver injuries, as determined by alanine
aminotransferase levels in plasma, were increased signiﬁcantly, conﬁrming that NKT cells are protective
for myocarditis but pathogenic in the liver. (Am J Pathol 2013, 182: 401e409; http://dx.doi.org/
10.1016/j.ajpath.2012.10.019)Supported by NIH grants HL108371 (S.A.H.) and AI067897 (J.B.).Myocarditis is an inﬂammation of the cardiac muscle that
follows microbial infections.1 Among viruses, enteroviruses
including coxsackie B viruses are common etiologic
agents.2,3 Although infectious agents act as a trigger for
myocarditis, there is considerable debate as to the actual
mechanism(s) of myocardial injury. Viruses directly cause
cellular dysfunction either through induced cell death, shut
down of cell RNA and protein synthesis, or viral protease
cleavage of contractile proteins.4,5 In addition, cytokines
such as IL-1b, IL-6, and tumor necrosis factor a, which are
elicited from resident cells in the heart subsequent to
infection, can suppress contractility, leading to cardiac
dysfunction.6 Finally, host immune responses to infection
may kill myocytes, leading to cardiac stress. Host response
can be directed speciﬁcally toward virally infected car-
diocytes or infection can trigger autoimmunity to cardiac
antigens (autoimmunity), which destroys both infected and
uninfected myocytes.7
Host innate immune responses occur rapidly, subsequent
to viral infections, and usually have broad speciﬁcity, unlikestigative Pathology.
.the classic adaptive immune response, which requires
a week or more for development of a measurable response
in the naive individual but is highly speciﬁc to the inducing
pathogen. The innate immune response both helps to control
microbe load before generation of the adaptive immune
response and has a major impact on the phenotype and
intensity of the adaptive response. Two types of T cells
representing innate immunity are natural killer T cells
(NKT) and T cells expressing the g-d T-cell receptor (gdþ).
A study by Wu et al8 showed that in vivo administration
of a-galactosylceramide, a ligand that speciﬁcally activates
NKT cells, protects mice from coxsackievirus B3
(CVB3)-induced myocarditis. Prior studies have shown that
signaling through Slam family receptors has a major impact
on NKT cell development,9e11 and that different Slam
haplotypes can have distinct effects on NKT cell response
and function.9,12 There are two major Slam haplotypes,
Slam haplotype 1 and Slam haplotype 2, that distinguish
Huber et alcommonly used inbred mouse strains.13,14 Slam haplotype 1
is present in C57Bl/6, and Slam haplotype 2 is present in
most other commonly used mouse strains including
129S1/SvImJ and BALB/c mice. The congenic B6.129c1
mouse expresses the genetic region of chromosome 1 con-
taining the 129-derived Slam haplotype 2 locus on the
C57Bl/6 background and was used previously to show Slam
haplotype control of liver NKT cell numbers and NKT cell
cytokine production.12 In addition, Slam haplotypes
previously were shown to regulate macrophage tumor
necrosis factor production in response to lipopolysaccha-
ride.12 Although less well studied, Slam familyereceptor
signaling also has been shown to affect gdþ T-cell devel-
opment. Studies using human peripheral blood mononuclear
cells stimulated in vitro with antibody to CD3 and either IL-
2, anti-CD150 (SLAM), or IL-15 showed that all three
stimulation protocols resulted in gdþ T-cell survival.
However, co-culture with anti-CD3 and anti-CD150 resul-
ted in selective proliferation of CD8þCD56þgdþ T cells
expressing the Vd1 chain, and cells co-cultured with anti-
CD3 and IL-15 resulted in preferential generation of
CD8CD56gdþ cells expressing the Vd2 chain.15 There-
fore, SLAM signaling can impact the generation of
a subpopulation of the total gdþ cell population in humans.
Prior studies from the Huber laboratory have shown that
a subpopulation of gdþ cells is crucial to myocarditis
susceptibility subsequent to CVB3 infection16 and that the
relevant gdþ cell expresses both CD8 and the Vg4
chain.16,17 This raised the question of whether Slam
haplotypes modulated selected gdþ cell subsets in the
mouse, as it does in humans, and whether the Slam haplo-
type speciﬁcally could affect activation of the CD8þVg4þ
T cell, which is known to be pathogenic in CVB3-induced
myocarditis.
CVB3 infection of mice results in multiple organ infection,
including pancreas, liver, and heart with accompanying tissue
injury in all tissues. There are well-established differences in
disease susceptibility between BALB/c and C57Bl/6 mice,
strains expressing the two distinct Slam haplotypes. C57Bl/6
mice are highly susceptible to type 2 autoimmune hepatitis
and develop extensive hepatic inﬂammation, whereas BALB/
c mice are resistant to this disease and show no inﬂamma-
tion.18 In contrast, BALB/c mice are more susceptible to
myocarditis19e22 compared with the more resistant C57Bl/6
strain. However, there are many genetic differences between
BALB/c and C57Bl/6 mice, which may inﬂuence disease
development or development and activation of speciﬁc innate
effectors such as NKT and gd T cells. The goal of the current
study was to determine whether Slam haplotype affected
NKT and Vg4þ T-cell responses subsequent to CVB3
infection using C57Bl/6 congenic mice in which the Slam
locus alone differed between the mouse strains, and whether
haplotype-dependent NKT/Vg4þ cell response had a distinct
effect in different organs infected with the virus in the
absence of the many other genetic differences between
BALB/c and C57Bl/6 mice.402Materials and Methods
Mice
Male C57Bl/6 mice were purchased from Jackson Labora-
tories (Bar Harbor, ME). B6.129c1 congenic mice have
been described previously,13 and a breeding colony of these
mice was maintained at the University of Vermont. All mice
were 5 to 7 weeks of age when infected. All of the studies
were reviewed and approved by the University of Vermont
Institutional Animal Care and Use Committee.
Virus
The H3 variant of CVB3 was made from an infectious
cDNA clone as described previously.23
Infection of Mice
Mice were injected i.p. with 102 plaque-forming units of
virus in 0.5 mL PBS. Animals were sacriﬁced when mori-
bund or 7 days after infection.
Virus Titers
Hearts and livers were removed aseptically from the
animals, weighed, and homogenized in RPMI 1640 medium
containing 5% fetal bovine serum, L-glutamine, strepto-
mycin, and penicillin. Cellular debris was removed by
centrifugation at 300  g for 10 minutes. Supernatants were
diluted serially using 10-fold dilutions and titered on Hela
cell monolayers by the plaque-forming assay.24
Histology
Tissue was ﬁxed in 10% buffered formalin for 48 hours,
parafﬁn-embedded, sectioned, and stained by H&E. The
percentage of the myocardium inﬂamed was determined on
at least two heart sections per animal using a Nikon Eclipse
50i microscope and a grid overlay. The number of grid
squares containing inﬂammation was divided by the total
grid squares of cardiac tissue (100) to determine the
percentage. Analysis was performed blindly on coded
slides. Evaluation of hepatic inﬂammation and necrosis was
too diffuse to measure the percentage of liver. Therefore,
liver was scored blindly on two sections per animal by using
coded slides and a scoring system of 0 to 4, where 0 was no
obvious inﬂammation or necrosis compared with liver from
uninfected animals, and 4 represents widespread and diffuse
lymphocytic inﬁltration and necrosis.
Isolation of Lymphocytes
Spleens were removed and pressed through ﬁne mesh
screens. Lymphoid cells were isolated by centrifugation
of cell suspensions on Histopaque (Sigma-Aldrich, St.
Louis, MO).ajp.amjpathol.org - The American Journal of Pathology
Figure 1 Slam locus polymorphisms control susceptibility to cardiac
and liver damage after CVB3 infection. C57Bl/6 (B6) and B6.129c1 male
mice were infected with CVB3 and sacriﬁced 7 days later. A: Hearts were
evaluated by image analysis for the percentage of myocardium inﬂamed. B:
Livers were scored using a scale of 0 to 4 for inﬂammation and hepatocyte
necrosis. Results represent the mean  SEM of 14 to 17 mice per strain. B6
data differ from B6.129c1 data at *P < 0.05 and **P < 0.01, respectively.
Figure 3 Cardiac and liver virus titers from mice in Figure 1. Hearts and
livers were weighed, homogenized, and titered by the plaque-forming
assay. Results represent the mean  SEM. Plaque-forming units per gram
of tissue from CVB3-infected B6 and B6.129c1 mice for which pathology
was reported in Figure 1. No signiﬁcant differences in virus titers were
observed between the two mouse strains.
Slam Locus Controls NKT and gd T CellsFlow Cytometry and Intracellular Cytokine Staining
Details for intracellular cytokine staining have been published
previously.25 Spleen cells (105) were cultured for 4 hours in
RPMI 1640 medium containing 10% fetal bovine serum,
antibiotics, 10 mg/mL Brefeldin A (Sigma), 50 ng/mL phorbol
myristate acetate (Sigma), and 500 ng/mL ionomycin (Sigma).
The cells were washed in PBSe1% bovine serum albumin
(BSA; Sigma) containing Brefeldin A, incubated on ice for 30
minutes in PBSeBSAeBrefeldin A containing a 1:100Figure 2 Representative histology of heart (A and D), liver (B and E),
and pancreas (C and F) of CVB3-infected B6 (A, B, and C) and B6.129c1 (D, E,
and F) mice, 7 days after infection. Tissue was formalin-ﬁxed, parafﬁn-
embedded, sectioned, and stained with H&E. Thick arrows indicate
inﬂammation in the various organs. Thin arrows indicate hepatic necrosis.
The American Journal of Pathology - ajp.amjpathol.orgdilution of Fc Block (BD Biosciences, San Jose CA), Alex-
a647eanti-CD8a, and peridinin-chlorophyll proteins-Cy5.5
(PerCP-Cy5.5) anti-CD4 (clone GK1.5), or PerCP-Cy5.5 and
Alexa647 rat IgG2b (clone A95-1, isotype controls). The cells
were washed once with PBSeBSAeBrefeldin A, ﬁxed in 2%
paraformaldehyde for 10 minutes, and then resuspended in
PBSeBSA containing 0.5% saponin, Fc Block, and 1:100
dilutions of phycoerythrin (PE) antieinterferon-g (IFN-g)
(clone XMG1.2) or PE-rat IgG1 (clone R3-34). All antibodies
were from BD Biosciences.
T regulatory cells were identiﬁed as CD4þFoxP3þ cell
populations. Cells labeled with anti-CD4 in PBSe1% BSA
containing Fc Block were washed, ﬁxed, and permeabilized
with PBSeBSAesaponin, and then incubated with
anti-FoxP3 (PEeanti-FoxP3; clone FJK-16s; eBiosciences,
San Diego, CA) and Fc Block for 2 hours at 4C. The cells
were washed once in PBSeBSAesaponin and once in
PBSeBSA and then resuspended in 2% paraformaldehyde.
Evaluation of NKT cells was performed by labeling spleen
cells with 1:100 dilutions of Fc Block, ﬂuoresceinFigure 4 Plasma was obtained by cardiac puncture into EDTA-treated
tubes and plasma was obtained by centrifugation. Aliquots of the plasma
were evaluated using commercial ELISA kits for mouse ALT and mouse cTnI
according to the manufacturer’s directions. Results are the mean  SEM of
5 to 10 mice per group. Signiﬁcant differences were noted between indi-
cated groups at *P < 0.05 and ** P < 0.01, respectively.
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Figure 6 Evaluation of the number of NKT cells and activated Vg4þ
cells in the spleen. NKT cells were identiﬁed by labeling spleen lymphocytes
with ﬂuorescein isothiocyanate antieT-cell receptor b and PE-mCD1d
tetramer. Activated Vg4þ cells were determined by labeling spleen cells
with PEeanti-gd TCR, FITCeanti-Vg4, and PerCPeCy5.5eanti-CD69, gating
on the gd TCRþ cells, and determining the Vg4þ CD69þ population. The
percentage of positive spleen cells for the indicated cellular antigens was
multiplied by the number of spleen cells isolated per individual spleen to
obtain the number of cells per spleen. Results are mean  SEM of ﬁve to
eight mice per group. *P < 0.05, **P < 0.01.
Huber et alisothiocyanate anti-CD4 (clone GK1.5), and PE-mCD1d/
PBS57, which was supplied by the NIH Tetramer Core
Facility at Emory University. Vg4þ cells were evaluated by
labeling spleen cells with 1:100 dilutions of Fc Block
PEeanti-gd T-cell receptor (clone GL3), ﬂuorescein isothio-
cyanateeanti-Vg4 (clone UC3-10A6), and PerCPeCy5.5e
anti-CD69. After incubation at 4C for 30 minutes, cells
were washed with PBSeBSA and resuspended in 2%
paraformaldehyde.
Cells were analyzed using a BD LSR II ﬂow cytometer (BD
Biosciences) with a single excitationwavelength (488 nm) and
band ﬁlters for PerCP-Cy5.5 (695/40 nm) and PE (575 nm).
The excitationwavelength forAlexa 647 is 643 nmwith a band
ﬁlter of 660/20 nm. The cell population was classiﬁed for cell
size (forward scatter) and complexity (side scatter). At least
10,000 cells were evaluated. Positive staining was determined
relative to isotype controls. To determine the number of indi-
vidual cell populations, the total number of viable cells was
determined by trypan blue exclusion.Afterﬂow cytometry, the
percentage of a subpopulation stainingwith a speciﬁc antibody
was multiplied by the total number of cells.Measurement of Alanine Aminotransferase
Mouse alanine aminotransferase (ALT) was determined in
plasma using a commercial enzyme-linked immunosorbent
assay (ELISA) kit for mouse ALT (MyBiosource, LLD, San
Diego, CA) according to the manufacturer’s directions. Kit
sensitivity was between 1 and 250 U/L. Plasma was used at
both undiluted and 1:2 dilutions in PBS to maintain values
within the range of the kit. Sample values were read at an
OD of 450 nm using an ELx 808 Ultra Microplate ReaderFigure 5 Number of T-regulatory (CD4þFoxP3þ), CD4þIFN-gþ, and
CD8þIFN-gþ cells in the spleens of B6 and B6.129c1 mice 7 days after CVB3
infection. For intracellular cytokine analysis, spleen cells were cultured for
4 hours in medium containing phorbol myristate acetate, ionomycin, and
Brefeldin A, washed, and then labeled with antibodies to CD4 or CD8. The
cells were ﬁxed, permeabilized, and labeled with antibody to IFN-g. For
T-regulatory cell analysis, spleen cells were labeled with antibody to CD4,
washed, ﬁxed, permeabilized, and labeled with antibody to FoxP3. To
determine the number of cells per spleen, the percentage of cells labeling
positively for the indicated markers (CD4þFoxP3þ; CD4þIFN-gþ or
CD8þIFN-gþ) was multiplied by the number of spleen cells. Results repre-
sent the mean  SEM of 14 to 17 mice per strain. Data for B6.129c1 mice
were either signiﬁcantly (*P < 0.05) or not signiﬁcantly different from
C57Bl/6 animals.
404(Bio-Tek, Inc, Winooski, VT) and concentrations were
calculated against a standard curve using standards supplied
in the kit.
Measurement of Mouse Troponin I
Mouse cardiac troponin I (cTnI) was measured in plasma
using a commercial kit from Life Diagnostics (West Ches-
ter, PA) according to the manufacturer’s directions. The
sensitivity of the kit was between 0.078 and 5 ng/mL.
Values were read at 450 nm and determined against a stan-
dard curve using standards supplied in the kit.
Treatment with a-GalCer
a-Galactosylceramide (a-GalCer) was purchased from
Avanti (Alabaster, AL), dissolved in dimethyl sulfoxide
(Sigma) at a concentration of 1 mg/mL, and then diluted to
a ﬁnal concentration of 4 mg/mL in PBS. Mice were injected
i.p. with 0.5 mL of the a-GalCer solution or equivalent
dimethyl sulfoxide/PBS vehicle control on day 3 after
infection.Figure 7 Histogram of NKT cells labeled with antibody to T-cell
receptor (TCR)b and mCD1d tetramer. FITC, ﬂuorescein isothiocyanate.
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Figure 8 Histogram of Vg4þ cells. A: Spleen cells were evaluated by
side scatter and anti-Vg4 antibody. Circled cells are Vg4þ. B: Spleen cells
were gated on the T-cell receptor gdþ population and then evaluated for
cells labeling positive for Vg4 and CD69.
Figure 9 Treatment of CVB3-infected C57Bl/6 mice with either
PBS/dimethyl sulfoxide (DMSO) (vehicle) or a-GalCer in PBS/DMSO. Mice
were infected with CVB3 and then injected i.p. with either vehicle alone or
2 mg a-GalCer on day three after infection. Mice were sacriﬁced 7 days after
infection and hearts (A) and livers (B) were evaluated for inﬂammation and
necrosis using H&Eestained slides of the tissue. Hearts (C) and livers (D)
Slam Locus Controls NKT and gd T CellsStatistics
Differences between groups were determined by the
Wilcoxon ranked score or c2 analysis.also were homogenized and the supernatants were titered for virus by the
plaque-forming assay. Results represent the mean  SEM of 5 to 10 mice
per group. Data for the a-GalCeretreated group were different from vehicle
control at *P < 0.05 and **P < 0.01, respectively.Results
Slam Haplotype Determines CVB3-Induced Pathology:
Inverse Relationship between Myocarditis and
Hepatitis
C57Bl/6 and B6.129c1 congenic mice were infected with
CVB3 and surviving mice were sacriﬁced 7 days later.
There was no signiﬁcant difference in animal survival to day
7 after infection (P > 0.05 by c2 analysis) between B6 (17
surviving of 33 total animals infected; 51.5%) and B6.129c1
(14 surviving of 44 total animals infected; 31.8%) mice.
Hearts and liver were evaluated histologically (Figures 1
and 2) and for virus titers (Figure 3). Myocardial inﬂam-
mation was reduced signiﬁcantly in B6.129c1 mice
compared with B6 animals subsequent to infection
(Figures 1A and 2D). In contrast liver inﬂammation
(Figure 2E) and hepatocyte necrosis (Figure 2E) were
increased in the B6.129c1 congenic animals compared with
B6 animals. Figure 1B shows the summary of hepatic
histology for all animals. Although there was a slight
decrease in virus titers in both livers and hearts of the
congenic mice compared with B6 animals, the difference
was not statistically signiﬁcant (Figure 3). Representative
histology is shown for hearts (Figure 2, A and D), livers
(Figure 2, B and E), and pancreas (Figure 2, C and F) of the
two strains of mice. Acinar cells in the pancreas of both B6
and B6.129c1 mice were degranulated equally, but there
was increased mononuclear cell inﬁltration in the pancreasThe American Journal of Pathology - ajp.amjpathol.orgof the B6.129c1 mice (Figure 2F). Neither uninfected B6
nor B6.129c1 mice showed any pathology of liver, heart, or
pancreas (data not shown). Injury to heart and liver was
conﬁrmed by measuring troponin I and ALT levels in
plasma (Figure 4). ALT values were increased signiﬁcantly
in CVB3 wild-type and CVB3-infected B6.129c1 mice
compared with uninfected control mice, but the levels in the
infected B6.129c1 animals was more than twice that in
infected B6 mice, conﬁrming the increased liver injury in
the B6.129c1 mice. In contrast, cTnI levels, although
increased in both infected B6 and B6.129c1 animals, was
signiﬁcantly greater in B6 than in B6.129c1-infected
animals.
Difference in Adaptive Immune Response Depending
on Slam Haplotype
Because the Slam haplotype had a signiﬁcant effect on the
pathology associated with CVB3 infection, the subsequent
question was whether activation of CD4þ or CD8þ T cells
was different in the wild-type and congenic mouse strains.
Spleen cells were isolated 7 days after infection. To evaluate
T-regulatory cell response, cells were labeled with antibody
to CD4, then intracellularly with antibody to FoxP3
(Figure 5A). There was a signiﬁcant increase in the total405
Figure 10 Plasma cTnI (A) and ALT (B) concentrations from mice
described in Figure 9. Plasma from individual mice infected with CVB3 and
treated 3 days after infection with either vehicle or a-GalCer was evaluated
for mouse ALT and cTnI using commercial ELISA kits. Results represent the
mean  SEM of 5 to 10 mice per group. a-GalCeretreated mice were
signiﬁcantly different from vehicle controls at *P < 0.05.
Huber et alnumber of T-regulatory cells in spleens of CVB3-infected
B6.129c1 mice compared with infected B6 mice (40%
increase). This change was speciﬁc to CVB3 infection
because there was no difference observed in the total
numbers of CD4þFoxP3þ cells in uninfected mice (data not
shown). Spleen cells also were activated with phorbol
myristate acetate and ionomycin in the presence of Brefeldin
A to allow evaluation of cytokine-positive T cells. The cells
were labeled with antibodies to CD4 and CD8, and then
intracellularly labeled with antibody to IFN-g (Figure 5,
B and C). There was a slight, but not signiﬁcant, reduction
in CD4þIFN-gþ cells but a signiﬁcant reduction in
CD8þIFN-gþ cells in CVB3-infected B6.129c1 compared
with B6 mice.Differences in Innate Effector Response with Slam
Haplotype
Prior studies have shown that although the total numbers of
NKT cells were equivalent in thymus and spleen between
B6 and B6.129c1 congenic mice, the B6.129c1 animals had
signiﬁcantly reduced numbers of NKT cells in the liver.12 In
addition, B6.129c1 mice produced signiﬁcantly less serum
cytokine in response to an in vivo lipopolysaccharide chal-
lenge compared with B6 animals.12 As shown earlier, the
cytokine response of B6.129c1 mice to CVB3 challenge
also was reduced, whereas the T-regulatory cell response
was increased. To investigate the effect of Slam haplotype
on NKT and gdþ T-cell responses subsequent to CVB3
infection, spleen cells from infected B6 and B6.129c1 mice
were labeled with antibodies to CD3, T-cell receptor d, and
Vg4, or with antibody to T-cell receptor b and the mCD1d
tetramer (Figure 6). These data showed that the total number
of splenic NKT cells (T-cell receptor bþCD1d tetramerþ)
were increased signiﬁcantly in B6.129c1 congenic mice
compared with B6 animals, whereas the opposite result was406observed with Vg4þ T cells (greater numbers in spleens of
B6 than B6.129c1 mice). Representative ﬂow diagrams for
NKT cells are shown in Figure 7, and for Vg4þ cells are
shown in Figure 8. In Figure 8, A and B, the percentage of
Vg4þ cells in the total lymphocyte population is shown for
C57Bl/6 and B6.129c1 mice. In Figure 8, C and D, ﬂow
analysis was ﬁrst gated on the total gdþ cell population,
then the Vg4þ and CD69þ populations were analyzed for
C57Bl/6 and B6.129c1 mice. CVB3 infection of B6 mice
resulted in approximately a threefold increase in Vg4þ cells
as a percentage of total lymphocytes, but a nearly 10-fold
increase as a percentage of total gdþ cells compared with
B6.129c1 mice. No differences were noted in the percentage
of Vg4þ cells in uninfected B6 and B6.129c1 mice, indi-
cating that the alteration in this subpopulation was a conse-
quence of Slam haplotype and infection.
Treatment of Mice with a-GalCer Modulates Both
Myocarditis and Hepatitis
The earlier-described data provide circumstantial evidence
that NKT cells promote hepatic pathology in CVB3 infec-
tion while potentially suppressing myocarditis. To conﬁrm
this observation, C57Bl/6 mice were infected with CVB3
and injected i.p. with either 2 mg a-GalCer in dimethyl
sulfoxide/PBS or with vehicle (dimethyl sulfoxide/PBS)
alone (Figure 9). Myocarditis was reduced signiﬁcantly in
C57Bl/6 mice given a-GalCer compared with vehicle
control, although hepatitis was increased signiﬁcantly.
Cardiac virus titers decreased modestly, but signiﬁcantly,
with a-GalCer treatment (Figure 9C). There was no signif-
icant change in virus titers in the liver (Figure 9D). Plasma
levels of ALT and troponin I are shown in Figure 10.
Treating infected B6 mice with a-GalCer resulted in
a twofold increase in ALT plasma levels compared with
infected mice treated with vehicle, as expected. In contrast,
a-GalCeretreated mice showed a signiﬁcant decrease in
cTnI concentrations, correlating with the decrease in
myocardial inﬂammation.Discussion
This study showed that Slam haplotypes control both NKT
and Vg4 T-cell responses to CVB3 infection, leading to
differences in severity of cardiac and hepatic injury from
infection. There appears to be a limited effect of Slam
haplotype on virus-induced acinar cell degranulation that
was equivalent in infected C57Bl/6 and B6.129c1 mice.
However, there was increased inﬂammatory cell inﬁltration
of the pancreas in infected B6.129c1 mice. Pancreatitis is
dependent on both T-celledependent immunity and
virus-induced injury in coxsackievirus-infected mice, but
the acute acinar degranulation may reﬂect viral injury alone
whereas progression to chronic pancreatitis depends on
proinﬂammatory host responses.26e28 Because survivingajp.amjpathol.org - The American Journal of Pathology
Slam Locus Controls NKT and gd T Cellsmice were sacriﬁced 7 days after infection, it was not
possible to determine whether the increased lymphocytic
inﬁltrate in B6.129c1 mice resulted in chronic pancreatitis;
the acinar damage in B6 mice represents the acute form
only. The histologic evidence for myocarditis and hepatitis
was conﬁrmed using assays evaluating c-troponin I and
ALT levels in plasma from infected mice. As shown
previously,16 the increased number of Vg4þ cells in infec-
ted C57Bl/6 mice correlates to myocarditis severity. Con-
genic B6.129c1 mice with the Slam haplotype 2 locus on the
C57Bl/6 background showed signiﬁcantly fewer Vg4þ cells
and myocardial inﬂammation, but had greater numbers of
NKT cells and enhanced hepatic injury, as noted both by
histologic evaluation of the liver and plasma ALT levels.
These results strongly indicate that although the Slam locus
regulates both NKT and Vg4þ cell responses subsequent to
CVB3 infection, it regulates these two innate effectors in
a fundamentally different manner. Studies using peripheral
blood mononuclear cells from healthy normal volunteers
indicated that in vitro stimulation with anti-CD3 and anti-
CD150 (SLAM) was effective in promoting the response
of a subpopulation of gdþ T cells expressing CD8 and
CD56, a cell surface marker found on natural killer cells.15
Because the relevant Vg4þ cell in CVB3-induced myocar-
ditis has been shown to express CD8,17 it seemed reason-
able that Slam family signaling might prove important in
activation of this subpopulation, as it was found to be in
human cells in vitro.
The observation that decreased numbers of NKT cells
correlated to poorer development of myocarditis is consis-
tent with the report of Wu et al,8 which showed that treating
CVB3-infected mice with a-GalCer protected them from
myocarditis and also reduced cardiac virus titers. Similar
results were obtained in an experimental autoimmune
myocarditis model in which in vivo administration of a-
GalCer resulted in reduced cardiac inﬂammation accompa-
nied by increases in T-regulatory cells.29 The protective
effects of NKT cells in autoimmune and CVB3-induced
myocarditis is in contrast to Lyme carditis, in which inﬁl-
tration of the myocardium with NKT cells is associated with
local production of IFN-g and inﬂammation.30 No pub-
lished reports address the presence or potential role of NKT
cells, or of Slam family molecules, in clinical myocarditis.
A growing body of literature supports a role for
NKT cells in hepatitis. It is now well accepted that conca-
navalin-Aemediated hepatitis, a classic mouse model of
immune-mediated liver injury, is an NKT celledependent
phenomenon.31e33 In addition, NKT cells have been
implicated in primary biliary cirrhosis in humans and in
mouse models,34e36 and in mouse models of nonalcoholic
steatohepatitis.37e40 A prominent role for NKT cells in liver
pathology perhaps is not unexpected, given that NKT cells
can comprise up to 50% of all liver ab T cells. In this
regard, it is interesting to note that liver NKT cell numbers
are particularly variable among different inbred strains of
mice.41 Additional studies will be needed to determineThe American Journal of Pathology - ajp.amjpathol.orgwhether liver NKT cells are involved directly in the hepatitis
observed in B6.129c1 mice after CVB3 infection.
In the current study, both cardiac and liver virus titers were
reduced per gram of tissuewith a-GalCer, but the trend did not
reach statistical signiﬁcance. This suggests that the protection
may not be mediated through direct NKT control of virus load
but may result from other mechanisms. T-regulatory cells
(CD4þFoxP3þ) are increased in myocarditis-resistant mice
whether the resistance results from infection with a non-
myocarditic CVB3 variant or infection of female mice in
which estrogen is protective.42e46 Furthermore, although
Vg4þ cells selectively kill T-regulatory cells in CVB3-
infected mice, leading to an increased proinﬂammatory
response,47,48 several studies have reported that NKT cells
can promote T-regulatory cell responses.49e52 Although
not investigated, the protection in a-GalCeretreated CVB3-
infected mice8 would be consistent with increases in T-
regulatory cell response, as well as with reduction in cardiac
virus titers.
B6.129c1 congenic mice possess a region of chromosome
1 encompassing the 129-derived Slam haplotype 2 locus, as
well as a number of other immunologically relevant
129-derived genes.12,13 Given the previous reports linking
Slam family receptors to innate immune function53 and to
NKT and gdþ T-cell development and function,10,11,15 we
speculate that Slam family receptors represent likely candi-
date genes to explain the phenotypes reported here. Although
the mechanisms through which the congenic interval regu-
lates NKT and gdþ T-cell numbers after CVB3 infection
remains unclear, we note that previous reports suggest that,
together with the signaling adapter protein Slam-associated
protein, Slam receptors can regulate T-cell activation and
proliferation54,55 and that Slamf6 in particular has been
shown to regulate restimulation-induced apoptosis in human
T cells.56 In addition, it previously was shown that expression
of certain Slam family receptors on NKT cells differs
signiﬁcantly between B6 and B6.129c1 mice,12 and that
Slamf6 (Ly108) appears to regulate liver NKT cell
number.11,57 Given the previous work showing the roles of
gdþ and NKT cells in the development of myocarditis,9e11,15
it is possible that genetic differences in Slam family loci could
regulate pathogenesis through the regulation of gdþ and
NKT cell expansion and/or contraction after CVB3 infection.Acknowledgments
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